PATENT CLAIM ANALYSIS

Application Number: 15747952
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-09
Patent Classification: ["548", "143000"]

Abstract:
The present invention relates to novel compounds represented by the formula I having histone deacetylase 6 (HDAC6) inhibitory activity, stereoisomers thereof or pharmaceutically acceptable salts thereof, the use thereof for the preparation of therapeutic medicaments, pharmaceutical compositions containing the same, a method for treating diseases using the composition, and methods for preparing the novel compounds. (I) The novel compounds, stereoisomers thereof or pharmaceutically acceptable salts thereof according to the present invention have histone deacetylase (HDAC) inhibitory activity and are effective for the prevention or treatment of HDAC6-mediated diseases.

Claim (Index 10):
A method for treating histone deacetylase-mediated disease, comprising administering a therapeutically effective amount of the compound represented by formula I, stereoisomer thereof or pharmaceutically acceptable salt thereof according to  claim 1 .

Metadata:
- Claim Count in Document: 1.0
- Percentile: 86.0
- Lexical Diversity: 1.82143
- Patent Class: 548.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15747850', '15748081', '15763972', '13093729', '14099276']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7538853416037309
- 35 USC 102 Novelty (BERT): 0.5448186087569978
- Combined Prediction Score: 0.7329786683190576
- Mean Citation Score: 349.8987160000001
- Max Citation Score: 412.90927
- Similarity Product: 320.10174141354685

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test